ArticleScientific reports2022

A novel glucagon analog with an extended half-life, HM15136, normalizes glucose levels in rodent models of congenital hyperinsulinism.

Yong Ho Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.